However, the researchers were able to identify only the presence of an adenocarcinoma as statistica

Medical Journal app, 08/28/2014
Cancer patients with stroke are at high risk, after suffering a thromboembolic event such as stroke, heart attack or thrombosis again immediately. This was a retrospective analysis in the United States arise.
New York. Cancer cells proliferate not only, they also secrete a wide variety of substances, procoagulant among others - these stimulate the coagulation and that in turn makes cancer patients prone to ischemic strokes.
If such elements are found, could also have consequences for the preventive treatment of cancer patients after stroke have - for Dr. Babak B. Navi from the Weill Cornell Medical College in New York and colleagues impetus to deal with this issue. High rates despite the short lifetime
The researchers collected data retrospectively from 2005 to 2009 by 236 cancer patients at Memorial plan b Sloan-Kettering plan b Cancer Center (MSKCC). Analyzed the incidence and characteristics of occurring in this group of patients relapsing Thomboembolien. The follow-up until death was available for 230 subjects.
The cumulative rates of recurrent thromboembolism were after one month at 21 percent, after three and six months at 31 and 37 percent, the rate for re strokes at 7, 13 and 16 percent - they were almost three times as high as in patients with stroke (: 26 83 Neurology 2014) but without cancer, the authors write. Adapt preventive therapy!
However, the researchers were able to identify only the presence of an adenocarcinoma as statistically significant independent risk factor for a recurrent thromboembolic event. Patients with this cancer diagnosis (60 percent in this population the most common) had a 65 percent increased risk (HR: 1.65).
The study authors conclude that patients with cancer, especially adenocarcinoma, after an acute ischemic stroke are at high risk, again suffering a stroke or other thromboembolic event - and that, although life expectancy in this group of patients is usually very short.
We still find the exact underlying pathophysiological mechanism, one could improve preventive therapy accordingly and thus perhaps get such complications in cancer patients in the future a better grip.
Topic Keywords plan b Cancer (8183) Stroke (1112) thrombosis / embolism (482) Neurology / Psychiatry (7919) Cardiology (675) Diseases of heart attack (2340) Stroke (2442) Thrombosis (335) tumor pain (1129) Veronika Schlimpert persons (10 )
Oncology: Boehringer secures cancer vaccine ASV: Next indications in the starting blocks brain tumor ?: warning signal when the headache plan b EU: Obinutuzumab against CLL now approved breakthrough pain: New brochure for melanoma patient: new drug application for immune-therapeutic breast cancer: Everolimus is used formerly Pediatric Oncology: Hope to individual therapies laboratory Tip: Tests for differential diagnosis of thrombocytopenia micronutrients: Can there be too much in this country?
The cleavage of the representative assemblies in an equal primary and specialty medical part is hotly debated. Now the KBV-Representative Assembly has adopted its own solution. But the rain already first concern. plan b more
The UN Security plan b Council plan b considers the Ebola epidemic is a major threat - and responded with resolution and special mission. Sierra Leone, however, has imposed a curfew and started a door-to-door screening. In Guinea allegedly killed applied villagers companion of Ebola reconnaissance squads. more
Brain tumor ?: warning signal when the headache Sigmund Freud: No rest on the couch Halle accepts no new customers with credit bureau entry drug supply: Pharmacists want uniform "Entlassrezept" "Diabetes @ Work": Concerted action will diabetics in business enterprises Syria: WHO wants in deaths plan b measles vaccination enlighten Baden-Württemberg: Campaign against bullying in school Westphalia: Hospital receives first Euregio-MRSA Seal Multiple Sclerosis: intestinal bacteria as primer? Oncology: Boehringer secures cancer vaccine
For some he is the unofficial "Nobel Prize" plan b for Pharmacology: the Galen von Pergamon Prize. Also this year he is again awarded - in the categories of Primary Care, Specialist Care, Orphan Drugs and basic research. Among the portraits of candidates
Venous disease and compression therapy
Other patient information colds "Alzheimer" Allergic rhinitis plan b eyes "blood donation campaign in Bavaria COPD Colon Cancer Green